Concepedia

Publication | Closed Access

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

DOI

404

Citations

25

References

2010

Year

Bradley J. Monk, Thomas J. Herzog, Stanley B. Kaye, Carolyn Krasner, Jan B. Vermorken, Franco M. Muggia, Éric Pujade-Lauraine, Alla Lisyanskaya, Janusz Rolski, Vera Gorbounova,
Journal of Clinical Oncology

Abstract

When combined with PLD, trabectedin improves PFS and ORR over PLD alone with acceptable tolerance in the second-line treatment of recurrent ovarian cancer.

References

YearCitations

Page 1